Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
07/2003
07/23/2003EP1328630A2 Secreted proteins
07/23/2003EP1328624A2 B7-like molecules and uses thereof
07/23/2003EP1328287A1 Compositions and methods for wt1 specific immunotherapy
07/23/2003EP1328151A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
07/23/2003EP1042459A4 Bifunctional molecules
07/23/2003CN1432064A Bi-functional cancer treatment agents
07/23/2003CN1432063A Humanised antibodies to epidermal growth factor receptor
07/23/2003CN1432024A Immunodominant acetylcholine receptor alpha subunit peptides
07/23/2003CN1431224A EJOI coding albumen of gene related to ovary growth of mitten crab
07/23/2003CN1431223A Recombination human cytomegalovirus fusion protein and its preparing method, application
07/22/2003US6596852 Antibodies that bind the cytokine designated LERK-5
07/22/2003US6596485 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries
07/17/2003WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
07/17/2003WO2003057708A2 Fusion proteins
07/17/2003WO2003057160A2 Compositions and methods for the diagnosis and treatment of tumor
07/17/2003WO2003057134A2 Specific binding agents of human angiopoietin-2
07/17/2003WO2002048195A3 Engineered stimulus-responsive switches
07/17/2003US20030135026 Compounds and methods for diagnosis of tuberculosis
07/17/2003US20030134787 Engineered to noncovalently bind to heat shock proteins; (ii) to compositions comprising such conjugate peptides, optionally bound to heat shock protein; and (iii) to methods of using such compositions to induce an immune response in a subject in
07/17/2003US20030134390 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing
07/17/2003US20030134350 Zinc finger domain recognition code and uses thereof
07/17/2003US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen.
07/17/2003US20030133909 An isolated polynucleotide encodes a polypeptide which comprising amino acids able to glycosylation, vaccines as an antitumor agent for treating mammal
07/17/2003CA2767061A1 Specific binding agents of human angiopoietin-2
07/17/2003CA2472328A1 Fusion proteins
07/17/2003CA2471431A1 Compositions and methods for the diagnosis and treatment of tumor
07/16/2003EP1327146A2 Compounds with a branched linker
07/16/2003EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137
07/16/2003EP1326976A1 Mfq-114, a human ajuba like protein
07/16/2003EP1326972A2 Transporters and ion channels
07/16/2003EP1326970A2 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome
07/16/2003EP1326897A2 Humanized anti-lt-beta-r antibodies
07/16/2003EP1326882A2 Enterokinase cleavage sequences and their use
07/16/2003EP1326881A1 PREPARATION OF CAPPED mRNA
07/16/2003EP0975354A4 Ligand/lytic peptide compositions and methods of use
07/16/2003EP0743856B1 Antigen-based heteropolymers for treating autoimmune diseases
07/16/2003EP0684956B1 Acylated protein aggregates and their use in enhancing signals in an immunoassay testing for antibodies
07/16/2003CN1429846A Tumour nascent blood ressel specificity conjugated polypeptide and human alpha interferon fusion protein and preparation
07/16/2003CN1429845A Mouse antichloromycetin monoclonal antibody and its use
07/15/2003US6593295 Long lasting insulinotropic peptides
07/15/2003US6593135 Quantitative analysis
07/15/2003US6593109 Culturing cells containing DNA sequences under the control of a regulatory sequence capable of directing expression; useful in treating bone defects, healing bone injury and wounds
07/15/2003US6593081 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
07/10/2003WO2003056017A2 Alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said alkaline protease
07/10/2003WO2003055980A2 Il-17 like molecules and uses thereof
07/10/2003WO2003055974A2 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease
07/10/2003WO2003055917A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003033677A3 Dimerized growth factor and materials and methods for producing it
07/10/2003WO2002092625A3 Moraxella(branhamella) catarrhalis antigens
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002012281A3 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
07/10/2003US20030131381 Novel ecdysone receptors and methods for their use
07/10/2003US20030130496 Immunoglobulins; cloning, amplifying and encoding by DNA sequences, polymerase chain reaction
07/10/2003US20030130494 Mammalian chemokine reagents
07/10/2003US20030130486 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129698 Involved in homo and heterotrimerization or oligomerization
07/10/2003US20030129587 Antigen/antibody specificity exchanger
07/10/2003US20030129586 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase.
07/10/2003US20030129195 Use of heat shock proteins
07/10/2003US20030129187 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
07/10/2003US20030129186 Compositions and methods for modulating blood-brain barrier transport
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
07/09/2003EP1325133A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus
07/09/2003EP1325130A2 Nogo receptor homologs
07/09/2003EP1325115A2 Cytokine receptor zcytor17
07/09/2003EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof
07/09/2003EP1325027A2 Casein peptide fragments with growth-influencing activity on cell cultures
07/09/2003EP1324771A2 Therapeutic antibodies
07/09/2003EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
07/09/2003EP0741787B1 Mammalian expression systems for hepatitis c virus envelope genes
07/09/2003EP0668924B1 HUMANIZED ANTIBODIES TO Fc RECEPTORS FOR IMMUNOGLOBULIN G ON HUMAN MONONUCLEAR PHAGOCYTES
07/09/2003EP0511308B2 Chimeric immunoglobulin for cd4 receptors
07/08/2003US6590140 Transgenic plant which expresses a polypeptide comprising given amino acid sequence; iron uptake; can be used to remove pollutants from soil or as nutritional supplements to treat iron- or zinc-deficiency
07/08/2003US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies
07/08/2003US6589764 IL-18 receptor fusion proteins
07/08/2003US6589530 Hepatitis B surface antigen vaccine
07/08/2003US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment
07/08/2003US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
07/08/2003CA2263883C Kuz, a novel family of metalloproteases
07/03/2003WO2003054213A2 NON-HUMAN PRIMATE Fc RECEPTORS AND METHODS OF USE
07/03/2003WO2003054194A2 Modified tridegins, production and use thereof as transglutaminase inhibitors
07/03/2003WO2003054185A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease
07/03/2003WO2003054184A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease
07/03/2003WO2003054142A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
07/03/2003WO2003054017A2 Mono-and dual chemokine/cytokine constructs
07/03/2003WO2003053467A1 Drug for regenerating tissue and vessel and method therefor
07/03/2003WO2003031590A3 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
07/03/2003WO2003025016A3 Trk polypeptide purification method
07/03/2003WO2003006623A3 Directed protein modificaiton by iterative sequence insertion
07/03/2003WO2002090495A8 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
07/03/2003WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto
07/03/2003WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/03/2003WO2001083750A9 Dendritic cell co-stimulator molecules
07/03/2003US20030126624 Chimeric DNA-binding proteins
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 295